Veerhealth Care secures ₹2.45 Crores repeat order from FMCG firm

1 min read     Updated on 18 May 2026, 04:33 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Veerhealth Care Limited announced a repeat order worth ₹2.45 Crores from a leading domestic FMCG company for personal care products, scheduled for execution within 45 days. The company, which holds USFDA plant clearance, projects revenues of ₹50-70 crores for FY 2026-27 and aims for ₹100 crores in the next 24 months.

powered bylight_fuzz_icon
40410481

*this image is generated using AI for illustrative purposes only.

Veerhealth Care Limited has secured a repeat order worth ₹2.45 Crores from one of India's leading FMCG companies for the supply of personal care products. The announcement was made on May 18, 2026, in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015.

Order Details

The order pertains to the supply of face care products to a domestic entity. The identity of the client has not been revealed, as the terms of the arrangement are confidential. The company is required to execute the order within a stipulated timeframe of 45 days. The buyer operates in the domestic and international markets in the 'personal and household care' segment and is part of a 125-year-old prominent business group.

The key parameters of the order are summarised below:

Parameter Details
Order Value ₹2.45 Crores
Nature of Order Supply of Face Care Products
Client Type Leading FMCG Company
Client Name Not disclosed (confidential terms)
Order Type Repeat Order
Execution Timeline 45 Days
Order Category Domestic

Future Outlook

Veerhealth Care specializes in manufacturing pure vegetarian toothpaste and has secured USFDA plant clearance, positioning it in a distinctive category among small-cap companies. For the fiscal year 2026-27, the company expects total revenues of ₹50-70 crores with a PAT of 7-10%. However, considering ongoing discussions for orders with both domestic and export buyers, revenues may exceed this guidance. The company anticipates reaching a revenue of ₹100 crores with a PAT of 10% in the next 24 months.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
-1.14%+0.96%+17.40%+26.54%+61.47%+157.66%

Could this repeat order from a 125-year-old FMCG conglomerate signal a long-term supply agreement, and what is the potential annual revenue Veerhealth Care could derive from scaling this partnership?

How might Veerhealth Care's USFDA plant clearance advantage position it to cross-sell its face care manufacturing capabilities to its existing US-based institutional clients?

Given the company's ayurvedic and natural ingredients focus, could rising consumer demand for clean-label personal care products accelerate Veerhealth Care's transition from oral care to a broader face and skin care contract manufacturer?

Veerhealth Care Ltd Announces Postal Ballot Results for Convertible Warrants Issuance

1 min read     Updated on 01 May 2026, 04:40 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Veerhealth Care Ltd successfully concluded its postal ballot process for convertible warrants issuance with overwhelming shareholder approval of 99.96%. The company received approval to issue up to 1,00,00,000 fully convertible warrants on preferential basis to promoter and non-promoter categories, with scrutinizer CS Nidhi Shah confirming all procedural requirements were met.

powered bylight_fuzz_icon
39178769

*this image is generated using AI for illustrative purposes only.

Veerhealth Care Ltd has successfully completed its postal ballot process for the issuance of fully convertible warrants, with shareholders providing overwhelming approval for the special resolution. The voting was conducted through remote e-voting from April 1, 2026 to April 30, 2026, in compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resolution Details

The postal ballot sought shareholder approval for the issuance of up to 1,00,00,000 fully convertible warrants to persons belonging to 'Promoter & Promoter Group Category' and 'Non-Promoter Category' on a preferential basis. The special resolution was passed with requisite majority as confirmed by the scrutinizer's report dated May 1, 2026.

Voting Results Summary

The voting results demonstrated strong shareholder support across all categories:

Category: Shares Held Votes Polled Votes in Favour % in Favour
Promoter and Promoter Group: 62,99,294 53,99,170 53,99,170 100.00
Public - Non Institutions: 1,36,99,182 3,13,601 3,11,489 99.33
Total: 1,99,98,476 57,12,771 57,10,659 99.96

Participation and Process Details

The record date for determining eligible shareholders was March 27, 2026, with 10,175 shareholders on record. A total of 85 shareholders participated through e-voting, casting 57,12,771 votes. The breakdown showed 79 voters assenting with 57,10,659 votes and 6 voters dissenting with 2,112 votes.

Voting Summary: Details
Total Shareholders on Record: 10,175
Shareholders Participated: 85
Assenting Voters: 79
Dissenting Voters: 6
Overall Approval Rate: 99.96%

Nidhi Shah & Associates was appointed as the scrutinizer on March 28, 2026, to conduct the postal ballot. CS Nidhi Shah confirmed that all votes cast were valid and reported that the special resolution was passed with the required majority. The voting results and scrutinizer's report have been made available on the company's website at veerhealthcare.net and on NSDL's platform.

Historical Stock Returns for Veerhealth Care

1 Day5 Days1 Month6 Months1 Year5 Years
-1.14%+0.96%+17.40%+26.54%+61.47%+157.66%

What is the intended use of funds from the 1 crore convertible warrants and how will this impact Veerhealth Care's expansion strategy?

How will the conversion of these warrants affect the ownership structure and dilution for existing shareholders?

What timeline has the company set for warrant conversion and what market conditions might influence conversion decisions?

More News on Veerhealth Care

1 Year Returns:+61.47%